Help

Search Results

17 results

  1. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 59

    An inter-laboratory comparison study focused on the determination of total NNAL in human urine

    NEWLAND K.(1); SCHERER M.(2); HECHT S.S.(3); TROUDE V.(4); PRASAD G.L.(5)
    (1) Celerion Inc., Lincoln, NE, U.S.A.; (2) ABF GmbH, Planegg, Germany; (3) University of Minnesota Cancer Center, Minneapolis, MN, U.S.A.; (4) Reemtsma Cigarettenfabriken GmbH, Imperial Brands plc, Hamburg, Germany; (5) RAI Services Company, Winston-Salem, NC, U.S.A.
    In an ongoing effort to fulfil the second objective of the CORESTA Biomarker Sub-Group, periodic inter-laboratory comparison studies have been performed to evaluate the consistency of the quantitation for various harmful or potentially harmful...
  2. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, ST 22

    Estimation of e-cigarette aerosol yields based on puff duration

    JULIEN R.(1); TSCHIERSKE N.(2); VARIGNON B.(1); TROUDE V.(1); DESTRUHAUT S.(1); WALELE T.(3); COLARD S.(1); CAHOURS X.(1)
    (1) SEITA-Imperial Tobacco Limited, Fleury-les-Aubrais, France; (2) Reemtsma Cigarettenfabriken GmbH (an Imperial Brands PLC Company), Hamburg, Germany; (3) Fontem Ventures B.V. (an Imperial Brands PLC Company), Amsterdam, The Netherlands
    There are regulatory requirements in quantifying and comparing the emission levels of major and minor aerosol constituents from e-cigarettes. Up until the recent publication in 2015 of CORESTA Recommended Method (CRM) No. 81 - "Routine Analytical...
  3. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, STPOST 07

    Consistency of bluTM e-cigarette nicotine delivery according to the AFNOR standard

    TSCHIERSKE N.(1); JULIEN R.(2); VARIGNON B.(2); TROUDE V.(2); DESTRUHAUT S.(2); WALELE T.(3); COLARD S.(2); CAHOURS X.(2)
    (1) Reemtsma Cigarettenfabriken GmbH (an Imperial Brands PLC Company), Hamburg, Germany; (2) SEITA-Imperial Tobacco Limited, Fleury-les-Aubrais, France; (3) Fontem Ventures B.V. (an Imperial Brands PLC Company), Amsterdam, The Netherlands
    Demonstrating the consistency of nicotine delivery from an e-cigarette is a requirement per EU Tobacco Product Directive (TPD) 2, Article 20, 3(f) (The European Council and the Council of the European Union, 2014). The Directive states that...
  4. CORESTA Congress, Berlin, 2016, Smoke Science/Product Technology Groups, STPOST 07

    Is a method to determine polycyclic aromatic hydrocarbons in cigarette smoke applicable to aerosols generated from heated tobacco products?

    GADOIS-POMMEREUL S.; BRU G.; PERROT R.; TROUDE V.
    SEITA-Imperial Tobacco, Fleury-les-Aubrais, France
    The market offers various new generation products, including heated tobacco products. In order to measure constituents in the aerosol of such products, methods developed for cigarette smoke were investigated for their applicability. This study is...
  5. CORESTA Meeting, Smoke Science/Product Technology, 2015, Jeju, ST 07

    Which parameters are suitable to evaluate e-vapour products puffing behaviour?

    TROUDE V.(1); WALELE T.(2); VERRON T.(1); DUPUTIE G.(1); PERROT R.(1)
    (1) SEITA, Imperial Tobacco Group, Fleury-les-Aubrais, France; (2) Imperial Tobacco Group, Bristol, U.K.
    The growing popularity of e-vapour products (EVP) carries with it an increasing interest in the examination of vaping behaviour. As part of a product stewardship programme to evaluate and assess e-vapour products prior to placing them on the...
  6. CORESTA Congress, Quebec, 2014, Smoke Science/Product Technology Groups, STPOST 14

    Electronic devices – investigation of the direct thermal extraction properties of the e-liquid

    GADOIS-POMMEREUL S.; REY M.; LHERMITE S.; TROUDE V.
    Imperial Tobacco Group, SEITA, Fleury-les-Aubrais, France
    The mode of action of a wide range of e-devices on the market is based on the transfer of e-liquid compounds through a heated air flow. The aim of this work was to provide a method to assess the e-device for qualitative screening of the vapour...
  8. CORESTA Meeting, Smoke Science/Product Technology, 2013, Seville, ST 19

    Human mouth-level transfer rate of menthol, 1.8-cineole and nicotine from Swedish pouched snus

    TROUDE V.(1); GADOIS-POMMEREUL S.(1); CLARKE A.(2); SIMMS L.(2)
    (1) SEITA, Imperial Tobacco Group, Fleury-les-Aubrais, France; (2) Imperial Tobacco Limited, Bristol, U.K.
    To facilitate the development of a transfer model which can be used to estimate human exposure to flavour and tobacco constituents, a human in vivo study involving 198 Swedish active snus users was conducted. All subjects agreed to participate in the...
  9. CORESTA Meeting, Smoke Science/Product Technology, 2013, Seville, STPOST 03

    Analytical method to model human mouth-level transfer of ingredients from Swedish pouched snus

    GRAPTON S. (1); GADOIS-POMMEREUL S.(1); TROUDE V.(1); BLANCHET M. (1); CLARKE A.(2); SIMMS L.(2)
    (1) SEITA, Imperial Tobacco Group, Fleury-les-Aubrais, France; (2) Imperial Tobacco Limited, Bristol, U.K.
    In parallel with the human study[1] a laboratory in vitro assay was conducted with three media: artificial saliva, water and 1% ß-cyclodextrin in water, using two snus products that were indistinguishable apart from the flavour application rate. To...
  10. CORESTA Meeting, Smoke Science/Product Technology, 2011, Graz, ST 07

    Relationship between puff intensity and smoke yields from a series of different smoking regimes

    TROUDE V.(1); PURKIS S.W.(2); CAHOURS X.(1)
    (1) SEITA, Imperial Tobacco Group, Fleury-les-Aubrais, France; (2) Imperial Tobacco Limited, Bristol, UK
    Imperial Tobacco Group data from two commercially available cigarettes, sold in the early 1980s and having 0 and 28% filter ventilation was presented this year at an ISO TC126 Working Group 10 meeting. The products had been smoked at different...